509 related articles for article (PubMed ID: 16027229)
21. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B₂ receptor.
Meini S; Bellucci F; Catalani C; Cucchi P; Giolitti A; Giuliani S; Quartara L; Rotondaro L; Zappitelli S; Maggi CA
Br J Pharmacol; 2011 Mar; 162(5):1202-12. PubMed ID: 21108627
[TBL] [Abstract][Full Text] [Related]
24. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
Kam YL; Ro JY; Kim HJ; Choo HY
Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
[TBL] [Abstract][Full Text] [Related]
25. Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle.
Meini S; Cucchi P; Catalani C; Bellucci F; Santicioli P; Giuliani S; Maggi CA
Eur J Pharmacol; 2010 Jun; 635(1-3):34-9. PubMed ID: 20307535
[TBL] [Abstract][Full Text] [Related]
26. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
[TBL] [Abstract][Full Text] [Related]
28. Modulation of nonadrenergic noncholinergic neural bronchoconstriction by bradykinin in anesthetized guinea pigs in vivo.
Miura M; Belvisi MG; Barnes PJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):482-6. PubMed ID: 7507996
[TBL] [Abstract][Full Text] [Related]
29. Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor.
Ichinose M; Barnes PJ
Am Rev Respir Dis; 1990 Nov; 142(5):1104-7. PubMed ID: 2173456
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of NPC-17731 on BK-induced and antigen-induced airway reactions in guinea-pigs.
Ikemura T; Sasaki Y; Ohmori K
Clin Exp Allergy; 1998 May; 28(5):635-43. PubMed ID: 9645601
[TBL] [Abstract][Full Text] [Related]
31. Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.
Bellucci F; Cucchi P; Catalani C; Giuliani S; Meini S; Maggi CA
Br J Pharmacol; 2009 Dec; 158(8):1996-2004. PubMed ID: 20050188
[TBL] [Abstract][Full Text] [Related]
32. Effect of CP-96,345, a non-peptide NK1 receptor antagonist, against substance P-, bradykinin- and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
Sakamoto T; Barnes PJ; Chung KF
Eur J Pharmacol; 1993 Jan; 231(1):31-8. PubMed ID: 7680318
[TBL] [Abstract][Full Text] [Related]
33. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
[TBL] [Abstract][Full Text] [Related]
34. Induction of bradykinin B1 hypotensive receptors in rats by lipopolysaccharide.
Nicolau M; Feltrin MR; Regoli D
Can J Physiol Pharmacol; 1996 Mar; 74(3):337-40. PubMed ID: 8773415
[TBL] [Abstract][Full Text] [Related]
35. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
38. Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies.
Meini S; Cucchi P; Bellucci F; Catalani C; Giuliani S; Santicioli P; Maggi CA
Br J Pharmacol; 2007 Feb; 150(3):313-20. PubMed ID: 17179941
[TBL] [Abstract][Full Text] [Related]
39. Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats.
Sharma JN; Stewart JM; Mohsin SS; Katori M; Vavrek R
Agents Actions Suppl; 1992; 38 ( Pt 3)():258-69. PubMed ID: 1334354
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin B2 receptors mediate pulmonary sympathetic afferents induced reflexes in rabbits.
Soukhova-O'Hare GK; Zhang JW; Gozal D; Yu J
Life Sci; 2006 Mar; 78(17):1990-7. PubMed ID: 16289619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
